##{"id":85190,"date":"2020-03-03T12:20:53","date_gmt":"2020-03-03T01:20:53","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=85190"},"modified":"2020-03-03T12:20:55","modified_gmt":"2020-03-03T01:20:55","slug":"sponsored-creso-pharma-brings-cannabis-products-to-scandinavia","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2020\/03\/03\/sponsored-creso-pharma-brings-cannabis-products-to-scandinavia\/","title":{"rendered":"SPONSORED: Creso Pharma Brings Cannabis Products To Scandinavia"},"content":{"rendered":"<p style=\"text-align:center\"><em>&#8211;The below is a company sponsored announcement&#8211;<\/em><\/p>\n<hr \/>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.fnarena.com\/ckfinder\/userfiles\/images\/Creso%20Hero%20Imager.jpeg\" style=\"height:668px;width:1002px\" \/><\/p>\n<p><strong>Cannabis has a place in global economies, but it seems the companies that will survive will be the ones who have a solid product offering that benefits consumers and therefore has a positive impact for investors.<\/strong><\/p>\n<p>One of these companies is Australian listed Creso Pharma ((CPH)).<\/p>\n<p>Creso&rsquo;s aims to become the world&rsquo;s most trusted supplier of cannabis and hemp-derived products and the company&rsquo;s experienced pharmaceutical leadership team has an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.<\/p>\n<p>Creso delivers products with standardized dosing and formulations through the application of pharmaceutical rigor, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.<\/p>\n<p>The company is not limited by any single market and can therefore offer a diverse portfolio of solutions to the widest possible population.<\/p>\n<p>Today, its commitment to bring to market products that make a difference in the lives of humans and animals has extended into the Scandinavian market.<\/p>\n<p>These are products that help manage pain, stress and anxiety and their importance shouldn&rsquo;t be underestimated by investors or the broader public.<\/p>\n<h2>Creso products to be sold in Norway<\/h2>\n<p>Creso Pharma has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.<\/p>\n<p>Farmagon is an established wholesale distributor in Norway, with over 25 years of experience in pharma in Scandinavia.&nbsp;<\/p>\n<p>Through this partnership, Creso expects to leverage Farmagon&rsquo;s licences, deep industry know-how and active retailer distribution channels to bring in-demand medical cannabis products to Scandinavia and surrounding markets.<\/p>\n<p>Under the agreement, Farmagon has the right to commercialise Creso&rsquo;s products under co-branding with Creso, or white labelling in the defined territory, subject to prescribed minimum order quantities.<\/p>\n<p>The first phase of the commercial roll out will be the focused on the launching of cannaQIX&reg; 50 and cannaQIX&reg; 10, both of which will be marketed as medicinal cannabis products under a required narcotics licence.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.fnarena.com\/ckfinder\/userfiles\/images\/Creso%20in%20article%20image%201.png\" \/><\/p>\n<h2>Supply chain advantages<\/h2>\n<p>In managing the sales operations, all aspects of the supply chain from medical professionals to shopfront and online distributors are in place.<\/p>\n<p>The sales channels will comprise doctors across a range of disciplines including alternative medicine, oncologists, neurologists and pain management doctors.<\/p>\n<p>In terms of the group&rsquo;s sales strategy, distribution to retail, pharmacies, drugstores, grocery shops and online is being coordinated.<\/p>\n<p>The agreement covers Norway as a commercial gateway as well as Denmark, Sweden and Finland, and can be terminated by either party giving 3 months&rsquo; notice.<\/p>\n<p>Highlighting Scandinavia&rsquo;s high-profile position in terms of science-based products, Creso Pharma&rsquo;s chief executive and co-founder Dr. Miri Halperin Wernli said, &ldquo;We are excited to enter the Scandinavian markets with our products.<\/p>\n<p>&lsquo;&rsquo;Besides being an attractive market, this will bring excellent opportunities as Scandinavia is a top-quality reference for marketing science-based products.<\/p>\n<p>Farmagon brings a wealth of experience to the table having operated for decades in the pharmaceutical space, whereby it now benefits from long-standing strong relationships across the supply chain, including an active retailer distribution network across the region.<\/p>\n<p>There are also obvious benefits that will flow from the group being an authorised wholesale organisation with narcotics licences for healthcare products for humans and animals in place.<\/p>\n<p>Chief executive and founder of Farmagon John Schnell said, &ldquo;We look forward to working together with Creso Pharma to realise this exciting opportunity.&rdquo;<\/p>\n<p>By Jonathan Jackson<\/p>\n<hr \/>\n<p><em>Earlier today the corporate announcement above was publicly released. FNArena is acting as a partner in&nbsp;distribution to broaden the reach. No journalists have been involved in the re-publication of this announcement.<\/em><\/p>\n<p><em>Find out why FNArena subscribers like the service so much: &quot;<a href=\"http:\/\/www.fnarena.com\/index4.cfm?type=dsp_newsitem&amp;n=29EB960D-9DFF-C00E-7F6B464E5D52E250\">Your Feedback (Thank You)<\/a>&quot; &#8211; Warning this story contains unashamedly positive feedback on the service provided.<\/em><\/p>\n<p><em>FNArena&nbsp;is proud about its track record and past achievements: <a href=\"https:\/\/www.fnarena.com\/index.php\/2018\/10\/03\/rudis-view-ten-years-on-the-world-is-still-turning\/\">Ten Years On<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cannabis has a place in global economies, but it seems the companies that will survive will be the ones who have a solid product offering that benefits consumers and therefore has a positive impact for investors.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/85190"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=85190"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/85190\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=85190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=85190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=85190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}